President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...
Paclitaxel is under clinical development by InnoUp Farma and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...
MET-3 is under clinical development by Nubiyota and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase II drugs for Hypertriglyceridemia have a 52% phase transition success ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback